Xiong P, Bondy M L, Li D, Shen H, Wang L E, Singletary S E, Spitz M R, Wei Q
Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Cancer Res. 2001 Dec 1;61(23):8465-9.
Mounting epidemiological evidence suggests that smoking may play a role in the etiology of breast cancer. Because smoking-related DNA adducts are detectable in both normal and malignant breast tissues, we hypothesized that breast cancer patients may be sensitive to tobacco-induced carcinogenesis, and this sensitivity could be modulated by variants of metabolic genes. To test this hypothesis, we evaluated benzo(a)pyrene diol-epoxide (BPDE)-induced mutagen sensitivity and polymorphisms of GSTM1 and GSTT1 in a pilot case-control study of breast cancer. Short-term cell cultures were established from blood samples of 100 female breast cancer patients and 105 healthy controls. After 5 h of in vitro exposure to 4 microM of BPDE, we harvested the lymphocytes for cytogenetic evaluation and recorded and compared the frequency of BPDE-induced chromatid breaks between cases and controls. We used a multiplex PCR-based assay to simultaneously detect polymorphisms of GSTM1 and GSTT1 from genomic DNA. We performed univariate and multivariate logistic regression analyses and calculated odds ratios (OR) and 95% confidence intervals (CIs). Cases had a significantly higher frequency of chromatid breaks than did controls (P < 0.0001). The level of chromatid breaks greater than the median value of controls was associated with a >3-fold increased risk of breast cancer [adjusted odds ratio (ORadj) = 3.11; 95% CI = 1.72-5.64]. The risk was more pronounced in those who were < 45 years (ORadj = 4.79; 95% CI = 1.87-12.3), ever-smokers (ORadj = 5.55; 95% CI = 1.85-16.6), alcohol drinkers (ORadj = 4.64; 95% CI = 1.70-12.7), and those who had the GSTT1 null variant (ORadj = 8.01; 95% CI = 1.16-55.3). These data suggest that sensitivity to BPDE-induced chromosomal aberrations may contribute to the risk of developing breast cancer, and such sensitivity may be modulated by both genetic and environmental factors. Larger studies are needed to confirm our findings.
越来越多的流行病学证据表明,吸烟可能在乳腺癌的病因学中起作用。由于在正常和恶性乳腺组织中都可检测到与吸烟相关的DNA加合物,我们推测乳腺癌患者可能对烟草诱导的致癌作用敏感,并且这种敏感性可能受代谢基因变体的调节。为了验证这一假设,我们在一项乳腺癌的初步病例对照研究中评估了苯并(a)芘二醇环氧化物(BPDE)诱导的诱变敏感性以及GSTM1和GSTT1的多态性。从100名女性乳腺癌患者和105名健康对照的血样中建立短期细胞培养物。在体外暴露于4 microM的BPDE 5小时后,我们收集淋巴细胞进行细胞遗传学评估,并记录和比较病例组和对照组中BPDE诱导的染色单体断裂频率。我们使用基于多重PCR的检测方法从基因组DNA中同时检测GSTM1和GSTT1的多态性。我们进行了单变量和多变量逻辑回归分析,并计算了比值比(OR)和95%置信区间(CIs)。病例组的染色单体断裂频率显著高于对照组(P < 0.0001)。染色单体断裂水平高于对照组中位数与乳腺癌风险增加>3倍相关[调整后的比值比(ORadj)= 3.11;95% CI = 1.72 - 5.64]。在年龄<45岁的人群(ORadj = 4.79;95% CI = 1.87 - 12.3)、曾经吸烟者(ORadj = 5.55;95% CI = 1.85 - 16.6)、饮酒者(ORadj = 4.64;95% CI = 1.70 - 12.7)以及具有GSTT1无效变体的人群(ORadj = 8.01;95% CI = 1.16 - 55.3)中,这种风险更为明显。这些数据表明,对BPDE诱导的染色体畸变的敏感性可能会增加患乳腺癌的风险,并且这种敏感性可能受遗传和环境因素的调节。需要更大规模的研究来证实我们的发现。